7RM Stock Chart & Stats
€15.89
-€0.22(-1.37%)
―
--
Day’s Range― - ―
52-Week Range€11.00 - €17.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)1.85K
Market Cap
€9.93B
Enterprise Value€11.97B
Total Cash (Recent Filing)€449.00M
Total Debt (Recent Filing)€3.28B
Price to Earnings (P/E)33.2
Beta>-0.01
Next Earnings
Jul 30, 2026EPS Estimate
0.69Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.48
Shares OutstandingN/A
10 Day Avg. Volume2,057
30 Day Avg. Volume1,846
Financial Highlights & Ratios
PEG Ratio-0.57
Price to Book (P/B)13.34
Price to Sales (P/S)1.05
P/FCF Ratio67.80
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€14.52Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering8
EPS Forecast (FY)0.93
Revenue Forecast (FY)€8.27B
Bulls Say, Bears Say
Bulls Say
Brand & Innovation MomentumA deep, diversified brand portfolio and faster idea-to-shelf execution support sustained pricing power and volume resilience. Durable brand-led innovations (flagship launches and Yasso growth) underpin market share gains and longer-term consumer preference, helping stabilize revenues across cycles.
Productivity Program DeliveryA material, multi-year productivity program that has already delivered significant savings structurally lowers the cost base and improves operating leverage. Continued program execution provides a durable margin buffer versus commodity swings and funds reinvestment for growth and capacity expansion.
Conservative Leverage And Financing AccessLeverage in line with policy and strong bond market reception signal durable access to capital and financial flexibility. This supports ongoing cabinet expansion, capex and separation costs without forcing distressed asset sales and helps execute strategic investments over the medium term.
Bears Say
Severe Cash Generation DeteriorationA near-collapse in free cash flow and weak cash conversion materially reduces self-funding capacity and increases reliance on external financing. Persistently weak FCF constrains capacity for organic investment, cushions against shocks, and pressures shareholder returns over the coming 2–6 months.
Sharp Revenue Decline And Margin CompressionA substantive revenue contraction combined with deteriorating margins reduces scale economics and raises questions about earnings sustainability. If top-line and margin trends do not reverse, profitability and reinvestment capacity may remain impaired beyond near-term commodity normalization.
Perimeter / India Acquisition DragAdding a low-EBITDA India perimeter and removal of prior royalties creates a structural reported-EBITDA headwind. Integration risk and near-term reported dilution could persist, limiting reported margin improvement and requiring sustained execution to realize any long-term benefits.
Magnum Ice Cream Co. N.V. News
7RM FAQ
What was Magnum Ice Cream Co. N.V.’s price range in the past 12 months?
Magnum Ice Cream Co. N.V. lowest stock price was €11.00 and its highest was €17.00 in the past 12 months.
What is Magnum Ice Cream Co. N.V.’s market cap?
Magnum Ice Cream Co. N.V.’s market cap is €9.93B.
When is Magnum Ice Cream Co. N.V.’s upcoming earnings report date?
Magnum Ice Cream Co. N.V.’s upcoming earnings report date is Jul 30, 2026 which is in 20 days.
How were Magnum Ice Cream Co. N.V.’s earnings last quarter?
Magnum Ice Cream Co. N.V. released its earnings results on Feb 12, 2026. The company reported €0.08 earnings per share for the quarter, missing the consensus estimate of €0.13 by -€0.05.
Is Magnum Ice Cream Co. N.V. overvalued?
According to Wall Street analysts Magnum Ice Cream Co. N.V.’s price is currently Undervalued.
Does Magnum Ice Cream Co. N.V. pay dividends?
Magnum Ice Cream Co. N.V. does not currently pay dividends.
What is Magnum Ice Cream Co. N.V.’s EPS estimate?
Magnum Ice Cream Co. N.V.’s EPS estimate is 0.69.
How many shares outstanding does Magnum Ice Cream Co. N.V. have?
Currently, no data Available
What happened to Magnum Ice Cream Co. N.V.’s price movement after its last earnings report?
Magnum Ice Cream Co. N.V. reported an EPS of €0.08 in its last earnings report, missing expectations of €0.13. Following the earnings report the stock price went down -18.385%.
Which hedge fund is a major shareholder of Magnum Ice Cream Co. N.V.?
Currently, no hedge funds are holding shares in DE:7RM
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Magnum Ice Cream Co. N.V. Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€14.52 (― Downside)
€14.52 (― Downside)
Blogger Sentiment
Bullish
DE:7RM Sentiment 70%
Sector Average ―
Sector Average ―
Insider Transactions
Bought Shares
Worth €5.2M over
the Last 3 Months
the Last 3 Months
Fundamentals
Return on Equity
79.30%
Trailing 12-Months
Asset Growth
53.83%
Trailing 12-Months
Company Description
Magnum Ice Cream Co. N.V.
Headquartered in Amsterdam, Noord-Holland, Netherlands, The Magnum Ice Cream Company N.V. specializes in the ice cream sector.
7RM Company Deck
7RM Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presents a constructive operational story: solid top-line performance (4.2% organic growth), positive volume growth, brand-led innovation and clear execution (market share gains and expanded cabinets), backed by a productivity program that has already delivered meaningful savings and a staged plan to reinvest for growth. Offsetting these positives are significant near-term headwinds and technical impacts: exceptional commodity inflation (380 bps) in 2025, TSA-related margin effects and separation/demerger cash costs that materially depressed reported EBITDA and free cash flow in the near term, plus acquisition-related perimeter dilution from India. Management frames most negatives as transitional or non-recurring (TSAs, separation costs, commodity normalization expected) while highlighting 2026 guidance for 3–5% organic growth and a 40–60 bps comparable adjusted EBITDA margin improvement. Given the balance of durable operational strengths and clear mitigation plans versus largely transitional and explainable near-term financial impacts, the overall tone is positive but pragmatic and execution-focused.View all DE:7RM earnings summaries7RM Stock 12 Month Forecast
All Analysts
Top Analysts
Average Price Target
€14.52
Options Prices
Currently, No data available
---






